DCOY 8-K 2026-07-15

Decoy Therapeutics Inc. (DCOY) 8-K dated 2026-07-15 — accession 0001193125-26-304949.

Decoy Therapeutics Inc. (DCOY) common stock.

Decoy Therapeutics Inc. filed a 8-K on 2026-07-15. Accession 0001193125-26-304949.

This 8-K covers: Shareholder vote results (Item 5.07). SEC EDGAR holds the official filing and its exhibits.

Latest reported DCOY revenue for 2026-06-30 was $227.6K. Net income was -$2.4M.

Not investment advice. The DCOY SEC hub lists recent forms. The stock page is the research view.